WD 40 CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that WD 40 CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Aug 31, 2021 | $488.11M | Oct 22, 2021 |
| FY2020 | Aug 31, 2020 | $408.50M | Oct 21, 2020 |
| FY2019 | Aug 31, 2019 | $423.35M | Oct 22, 2019 |
| FY2018 | Aug 31, 2018 | $408.52M | Oct 22, 2018 |
| FY2018 | Aug 31, 2017 | $380.51M | Oct 22, 2018 |
| FY2018 | Aug 31, 2016 | $380.67M | Oct 22, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $619.99M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $590.56M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $537.26M | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $518.82M | Oct 21, 2024 |
| FY2023 | Aug 31, 2021 | $488.11M | Oct 23, 2023 |
| FY2022 | Aug 31, 2020 | $408.50M | Oct 24, 2022 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Aug 31, 2017 | $380.51M | Oct 23, 2017 |
| FY2017 | Aug 31, 2016 | $380.67M | Oct 23, 2017 |
| FY2017 | Aug 31, 2015 | $378.15M | Oct 23, 2017 |
| FY2016 | Aug 31, 2014 | $383.00M | Oct 24, 2016 |
| FY2015 | Aug 31, 2013 | $368.55M | Oct 22, 2015 |
| FY2014 | Aug 31, 2012 | $342.78M | Oct 21, 2014 |
| FY2013 | Aug 31, 2011 | $336.41M | Oct 22, 2013 |
| FY2012 | Aug 31, 2010 | $321.52M | Oct 22, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $341.34M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $315.23M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $274.22M | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $254.77M | Oct 21, 2024 |
| FY2023 | Aug 31, 2021 | $263.74M | Oct 23, 2023 |
| FY2022 | Aug 31, 2020 | $223.02M | Oct 24, 2022 |
| FY2021 | Aug 31, 2019 | $232.34M | Oct 22, 2021 |
| FY2020 | Aug 31, 2018 | $225.26M | Oct 21, 2020 |
| FY2019 | Aug 31, 2017 | $213.89M | Oct 22, 2019 |
| FY2018 | Aug 31, 2016 | $214.37M | Oct 22, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $90.99M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $69.64M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $65.99M | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $67.33M | Oct 21, 2024 |
| FY2023 | Aug 31, 2021 | $70.23M | Oct 23, 2023 |
| FY2022 | Aug 31, 2020 | $60.71M | Oct 24, 2022 |
| FY2021 | Aug 31, 2019 | $55.91M | Oct 22, 2021 |
| FY2020 | Aug 31, 2018 | $65.22M | Oct 21, 2020 |
| FY2019 | Aug 31, 2017 | $52.93M | Oct 22, 2019 |
| FY2018 | Aug 31, 2016 | $52.63M | Oct 22, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $103.79M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $96.35M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $89.72M | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $87.33M | Oct 21, 2024 |
| FY2023 | Aug 31, 2021 | $88.84M | Oct 23, 2023 |
| FY2022 | Aug 31, 2020 | $77.22M | Oct 24, 2022 |
| FY2021 | Aug 31, 2019 | $82.38M | Oct 22, 2021 |
| FY2020 | Aug 31, 2018 | $78.60M | Oct 21, 2020 |
| FY2019 | Aug 31, 2017 | $75.91M | Oct 22, 2019 |
| FY2018 | Aug 31, 2016 | $71.35M | Oct 22, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $8.70M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $8.00M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $6.20M | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $5.10M | Oct 21, 2024 |
| FY2023 | Aug 31, 2021 | $5.60M | Oct 23, 2023 |
| FY2022 | Aug 31, 2020 | $6.00M | Oct 24, 2022 |
| FY2021 | Aug 31, 2019 | $6.50M | Oct 22, 2021 |
| FY2020 | Aug 31, 2018 | $7.00M | Oct 21, 2020 |
| FY2019 | Aug 31, 2017 | $8.40M | Oct 22, 2019 |
| FY2018 | Aug 31, 2016 | $7.70M | Oct 22, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $199.94M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $183.86M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $154.68M | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $138.66M | Oct 21, 2024 |
| FY2023 | Aug 31, 2021 | $145.49M | Oct 23, 2023 |
| FY2022 | Aug 31, 2020 | $121.98M | Oct 24, 2022 |
| FY2021 | Aug 31, 2019 | $123.95M | Oct 22, 2021 |
| FY2020 | Aug 31, 2018 | $121.39M | Oct 21, 2020 |
| FY2019 | Aug 31, 2017 | $114.56M | Oct 22, 2019 |
| FY2018 | Aug 31, 2016 | $117.77M | Oct 22, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $87.93M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $92.03M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $98.39M | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $2.60M | Oct 21, 2024 |
| FY2023 | Aug 31, 2021 | $84.71M | Oct 23, 2023 |
| FY2022 | Aug 31, 2020 | $72.66M | Oct 24, 2022 |
| FY2021 | Aug 31, 2019 | $62.85M | Oct 22, 2021 |
| FY2020 | Aug 31, 2018 | $64.82M | Oct 21, 2020 |
| FY2019 | Aug 31, 2017 | $55.57M | Oct 22, 2019 |
| FY2018 | Aug 31, 2016 | $65.30M | Oct 22, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $4.53M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $4.21M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $6.87M | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $8.30M | Oct 21, 2024 |
| FY2023 | Aug 31, 2021 | $15.06M | Oct 23, 2023 |
| FY2022 | Aug 31, 2020 | $19.31M | Oct 24, 2022 |
| FY2021 | Aug 31, 2019 | $13.28M | Oct 22, 2021 |
| FY2020 | Aug 31, 2018 | $12.36M | Oct 21, 2020 |
| FY2019 | Aug 31, 2017 | $20.15M | Oct 22, 2019 |
| FY2018 | Aug 31, 2016 | $4.35M | Oct 22, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $475.81M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $449.04M | Oct 27, 2025 |
| FY2024 | Aug 31, 2023 | $437.97M | Oct 21, 2024 |
| FY2023 | Aug 31, 2022 | $434.30M | Oct 23, 2023 |
| FY2022 | Aug 31, 2021 | $430.20M | Oct 24, 2022 |
| FY2021 | Aug 31, 2020 | $362.64M | Oct 22, 2021 |
| FY2020 | Aug 31, 2019 | $302.66M | Oct 21, 2020 |
| FY2019 | Aug 31, 2018 | $317.06M | Oct 22, 2019 |
| FY2018 | Aug 31, 2017 | $369.72M | Oct 22, 2018 |
| FY2017 | Aug 31, 2016 | $339.67M | Oct 23, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $207.66M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $218.51M | Oct 27, 2025 |
| FY2024 | Aug 31, 2023 | $227.79M | Oct 21, 2024 |
| FY2023 | Aug 31, 2022 | $245.67M | Oct 23, 2023 |
| FY2022 | Aug 31, 2021 | $229.82M | Oct 24, 2022 |
| FY2021 | Aug 31, 2020 | $202.32M | Oct 22, 2021 |
| FY2020 | Aug 31, 2019 | $157.19M | Oct 21, 2020 |
| FY2019 | Aug 31, 2018 | $161.57M | Oct 22, 2019 |
| FY2018 | Aug 31, 2017 | $230.33M | Oct 22, 2018 |
| FY2017 | Aug 31, 2016 | $199.27M | Oct 23, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $268.15M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $230.53M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $210.18M | Oct 27, 2025 |
| FY2025 | Aug 31, 2022 | $188.62M | Oct 27, 2025 |
| FY2024 | Aug 31, 2021 | $200.38M | Oct 21, 2024 |
| FY2023 | Aug 31, 2020 | $160.31M | Oct 23, 2023 |
| FY2022 | Aug 31, 2019 | $145.48M | Oct 24, 2022 |
| FY2021 | Aug 31, 2018 | $155.49M | Oct 22, 2021 |
| FY2020 | Aug 31, 2017 | $139.39M | Oct 21, 2020 |
| FY2019 | Aug 31, 2016 | $140.40M | Oct 22, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $97.15M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $96.99M | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | $95.51M | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | $95.18M | Oct 21, 2024 |
| FY2023 | Aug 31, 2021 | $95.87M | Oct 23, 2023 |
| FY2022 | Aug 31, 2020 | $95.73M | Oct 24, 2022 |
| FY2021 | Aug 31, 2019 | $95.35M | Oct 22, 2021 |
| FY2020 | Aug 31, 2018 | $95.62M | Oct 21, 2020 |
| FY2019 | Aug 31, 2017 | $95.60M | Oct 22, 2019 |
| FY2018 | Aug 31, 2016 | $95.65M | Oct 22, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $540.67M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $499.93M | Oct 27, 2025 |
| FY2024 | Aug 31, 2023 | $477.49M | Oct 21, 2024 |
| FY2023 | Aug 31, 2022 | $456.08M | Oct 23, 2023 |
| FY2022 | Aug 31, 2021 | $430.74M | Oct 24, 2022 |
| FY2021 | Aug 31, 2020 | $398.73M | Oct 22, 2021 |
| FY2020 | Aug 31, 2019 | $374.06M | Oct 21, 2020 |
| FY2019 | Aug 31, 2018 | $351.27M | Oct 22, 2019 |
| FY2018 | Aug 31, 2017 | $315.76M | Oct 22, 2018 |
| FY2017 | Aug 31, 2016 | $289.64M | Oct 23, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $58.13M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $46.70M | Oct 27, 2025 |
| FY2024 | Aug 31, 2023 | $48.14M | Oct 21, 2024 |
| FY2023 | Aug 31, 2022 | $37.84M | Oct 23, 2023 |
| FY2022 | Aug 31, 2021 | $85.96M | Oct 24, 2022 |
| FY2021 | Aug 31, 2020 | $56.46M | Oct 22, 2021 |
| FY2021 | Aug 31, 2019 | $27.23M | Oct 22, 2021 |
| FY2021 | Aug 31, 2018 | $48.87M | Oct 22, 2021 |
| FY2020 | Aug 31, 2017 | $37.08M | Oct 21, 2020 |
| FY2019 | Aug 31, 2016 | $50.89M | Oct 22, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $86.20M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | $85.98M | Oct 27, 2025 |
| FY2024 | Aug 31, 2023 | $109.74M | Oct 21, 2024 |
| FY2023 | Aug 31, 2022 | $107.14M | Oct 23, 2023 |
| FY2022 | Aug 31, 2021 | $114.94M | Oct 24, 2022 |
| FY2021 | Aug 31, 2020 | $113.10M | Oct 22, 2021 |
| FY2020 | Aug 31, 2019 | $60.22M | Oct 21, 2020 |
| FY2019 | Aug 31, 2018 | $62.80M | Oct 22, 2019 |
| FY2018 | Aug 31, 2017 | $134.00M | Oct 22, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | 6 | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | 5 | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | 4 | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | 4 | Oct 21, 2024 |
| FY2023 | Aug 31, 2021 | 5 | Oct 23, 2023 |
| FY2022 | Aug 31, 2020 | 4 | Oct 24, 2022 |
| FY2021 | Aug 31, 2019 | 4 | Oct 22, 2021 |
| FY2020 | Aug 31, 2018 | 4 | Oct 21, 2020 |
| FY2019 | Aug 31, 2017 | 3 | Oct 22, 2019 |
| FY2018 | Aug 31, 2016 | 3 | Oct 22, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | 6 | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | 5 | Oct 27, 2025 |
| FY2025 | Aug 31, 2023 | 4 | Oct 27, 2025 |
| FY2024 | Aug 31, 2022 | 4 | Oct 21, 2024 |
| FY2023 | Aug 31, 2021 | 5 | Oct 23, 2023 |
| FY2022 | Aug 31, 2020 | 4 | Oct 24, 2022 |
| FY2021 | Aug 31, 2019 | 4 | Oct 22, 2021 |
| FY2020 | Aug 31, 2018 | 4 | Oct 21, 2020 |
| FY2019 | Aug 31, 2017 | 3 | Oct 22, 2019 |
| FY2018 | Aug 31, 2016 | 3 | Oct 22, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | 13.53M | Oct 27, 2025 |
| FY2025 | Aug 31, 2024 | 13.55M | Oct 27, 2025 |
| FY2024 | Aug 31, 2023 | 13.56M | Oct 21, 2024 |
| FY2023 | Aug 31, 2022 | 13.60M | Oct 23, 2023 |
| FY2022 | Aug 31, 2021 | 13.71M | Oct 24, 2022 |
| FY2021 | Aug 31, 2020 | 13.66M | Oct 22, 2021 |
| FY2020 | Aug 31, 2019 | 13.72M | Oct 21, 2020 |
| FY2019 | Aug 31, 2018 | 13.85M | Oct 22, 2019 |
| FY2018 | Aug 31, 2017 | 13.98M | Oct 22, 2018 |
| FY2017 | Aug 31, 2016 | 14.21M | Oct 23, 2017 |